Explore our new Cybersecurity Terms Glossary, explained by our experts.

View the Glossary View the Glossary
PRIVIA

Cybersecurity Terms Glossary

What Is the Pharmaceutical Track and Trace System?

Turkey’s pharmaceutical track and trace system records every movement of every medicine pack from manufacture to dispensing, a full traceability model that the UK has never operated.

Illustration for the cybersecurity term Pharmaceutical Track and Trace System
Home / Blog / Cybersecurity Terms / What Is the Pharmaceutical Track and Trace System?
17 November 2026

What Is the Pharmaceutical Track and Trace System?

What Is the Pharmaceutical Track and Trace System?

Turkey operates one of the oldest and most complete medicine traceability systems in the world. Known in Turkish as the Ilac Takip Sistemi and usually abbreviated to ITS, it has been running since 2010 under the Turkish Medicines and Medical Devices Agency. Every pack of a prescription medicine carries a two-dimensional barcode containing a global trade item number, a unique serial number, a batch number, and an expiry date, and every change of custody is reported to the central system: dispatch from the manufacturer, receipt by the warehouse, sale to the pharmacy, dispensing to the patient, return, and destruction.

The distinction that matters is between tracking and verification. Turkey tracks: the central database knows where each individual pack is at each point in the chain. The European model that the UK used to participate in verifies: a pack is checked against a repository at the point of dispensing to confirm the serial number is genuine and has not been used, without recording the intermediate journey.

What the System Delivers

The Security Problem It Creates

A traceability system of this kind is a high-integrity database with thousands of writers, and the risk profile follows from that.

  1. Credential compromise at a participant. A pharmacy or warehouse account can be used to record movements that never happened, laundering diverted or falsified stock into the legitimate chain. Participant authentication is the system’s weakest point by design, because the participants are small businesses.
  2. Serial number harvesting. Valid serial numbers are visible on packaging and in waste, and counterfeiters who collect them can produce packs that pass a superficial check.
  3. Integration security. Manufacturers and wholesalers connect their enterprise systems to the central service through interfaces that hold credentials and certificates, and those integration servers are frequently old and poorly monitored.
  4. Serialisation line integrity. Packaging lines print and verify codes under the control of ordinary industrial systems, so manipulation of the line software corrupts the data at source, which is an operational technology problem rather than a database one.
  5. Availability. When the central system or a pharmacy’s connection is unavailable, dispensing stops or falls back to a manual process that must later be reconciled.
  6. Commercial confidentiality. Movement data reveals a competitor’s distribution patterns, which makes read access as sensitive as write access.

Where the UK Stands

Britain’s position changed with Brexit. The Falsified Medicines Directive applied in the UK until 31 December 2020, and community pharmacies scanned packs against the European repository. From 1 January 2021 Great Britain left that system, and the safety features requirement no longer applies to medicines supplied in England, Scotland, and Wales. Northern Ireland continued under the European arrangements for a period under the Windsor Framework, and from 1 January 2025 the EU system ceased to apply there as well.

The result is that the UK currently has no mandatory national serialisation or verification scheme, though the MHRA has consulted on a future UK-wide approach and the sector has kept much of the technical capability in place. Assurance in the UK supply chain therefore rests on wholesale dealer licensing, good distribution practice, and the strength of individual supply agreements rather than on a central ledger.

What This Means for a UK Business

If you manufacture or export medicines to Turkey, serialisation and notification are entry conditions, not optional capabilities. Your packaging lines must apply compliant codes, your enterprise systems must report movements to the central service within the required timescales, and your Turkish partner will hold credentials that transact in your name. Three practical points follow.

First, treat the integration credentials as privileged and rotate them, because a compromised interface account can create movement records that implicate your product. Second, include serialisation data integrity in your supply chain risk assessment, including the packaging line. Third, remember that pack movement data about Turkish patients and pharmacies is personal data for some participants, which brings KVKK obligations and the cross-border transfer rules into scope if that data reaches a UK system.

Where a manufacturing or distribution environment needs its serialisation and integration path assessed, our infrastructure and architecture review services cover the line systems and the enterprise interfaces together.

FAQ – Frequently Asked Questions

How Does Turkey’s System Differ from the EU Approach?

Turkey records every custody change for every pack in a central system, giving full traceability from manufacture to dispensing. The European Falsified Medicines Directive model verifies a pack against a repository at the point of dispensing without recording the intermediate journey. Turkey’s approach yields far richer data and far greater exposure if that data or its integrity is compromised.

Does the UK Still Require Medicine Serialisation?

Not at present. The Falsified Medicines Directive ceased to apply to Great Britain on 31 December 2020 and to Northern Ireland from 1 January 2025 under the Windsor Framework arrangements. The MHRA has consulted on a future UK scheme, but there is currently no mandatory national verification requirement, and assurance rests on licensing, good distribution practice, and contracts.

What Is the Biggest Security Risk in a Traceability System?

Compromised participant credentials. Thousands of pharmacies, warehouses, and hospitals write to the central database, and an attacker using a legitimate account can record movements that never occurred, which is exactly how diverted or falsified product is given a clean history. Strong authentication for participants and anomaly detection on movement patterns matter more than perimeter controls at the centre.

Is Serialisation Data Personal Data?

Parts of it can be. Movement records that tie a specific pack of a specific medicine to a dispensing event can identify or relate to a patient, which makes them health data in the hands of participants that hold the patient link. Under KVKK that attracts the special category regime, and any transfer of such data out of Turkey needs an approved mechanism.

Related Terms

You May Be Interested In These

What Is Burp Suite?

Cybersecurity Terms

17 November 2026

What Is Burp Suite?

Read More
What Is a Cloud Workload Protection Platform?

Cybersecurity Terms

17 November 2026

What Is a Cloud Workload Protection Platform?

Read More
What Is Alert Enrichment Automation?

Cybersecurity Terms

17 November 2026

What Is Alert Enrichment Automation?

Read More